首页工具

登录

搜索结果

Search Results for " akt2 "

48

抑制剂 & 化合物

1

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T14152	Akt1 and Akt2-IN-1	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50=3.5 nM) and Akt2 (IC50=42 nM). It has potent and balanced activity.
T3467	Miransertib ARQ-092,AKT inhibitor 2	Akt; Parasite	Cytoskeletal Signaling; Microbiology/Virology; PI3K/Akt/mTOR signaling
	Miransertib (ARQ-092) 是一种具有口服活性的，选择性和变构性Akt 抑制剂。它有效抑制利什曼原虫，还是 AKT1-E17K 突变蛋白抑制剂，可研究PI3K/AKT 驱动的肿瘤和 Proteus 综合征。
T15374	Ipatasertib dihydrochloride GDC-0068 dihydrochloride,RG-7440 dihydrochloride	Akt; PKA	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
	Ipatasertib dihydrochloride (GDC-0068 dihydrochloride) 是ATP 竞争性的pan-Akt 选择性抑制剂，抑制Akt1，Akt2，Akt3，IC50分别为 5，18，8 nM。
T7885	Afuresertib hydrochloride	ROCK; Akt; PKC	Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Stem Cells
	Afuresertib hydrochloride 是一个口服有效的，ATP 竞争性的选择性泛Akt 抑制剂，作用于Akt1、Akt2和Akt3，Ki 值分别为 0.08、2和 2.6 nM。
T23695	Akt-I-1,2	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Akt-I-1,2 是 Akt1 和 Akt2 的选择性抑制剂。
T7315	BAY1125976	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	BAY1125976 是选择性Akt1/Akt2变构抑制剂。在10 μM ATP 时，它抑制 Akt1 和 Akt2 活性的IC50值分别为 5.2 nM 和 18 nM。
T1952	MK-2206 dihydrochloride MK-2206 2HCl	Apoptosis; Akt; Autophagy	Apoptosis; Autophagy; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	MK-2206 dihydrochloride (MK-2206 2HCl) 是一种变构 Akt 抑制剂，抑制 Akt1、Akt2 和 Akt3 (IC50=8/12/65 nM)，具有口服活性的、高效选择性。MK-2206 dihydrochloride 具有抗肿瘤活性。
T38846	Vevorisertib trihydrochloride ARQ 751 trihydrochloride	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Vevorisertib trihydrochloride(ARQ 751 trihydrochloride) 是一种具有选择性和有效性的 pan-AKT 和 AKT1-E17K 突变抑制剂，抑制 AKT1 、AKT2 和 AKT3 。 Vevorisertib trihydrochloride 可用于研究肝癌和晚期实体瘤。
T14072	A-443654	ERK; VEGFR; GSK-3; FLT; Casein Kinase; MAPK; Akt; PKA; Chk; CDK; Src; PKC; S6 Kinase	Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors
	A-443654 是 pan-Akt 抑制剂，对Akt1，Akt2，和Akt3具有同等效力的抑制作用，Ki=均为 160 pM。
T39733	Hu7691 free base	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Hu7691 free base 是一种具有口服活性、高效性和选择性的 Akt 抑制剂，对多种神经母细胞瘤细胞系的抗增殖和神经发生作用。Hu7691 free base 抑制 Akt1、Akt2 和 Akt3 ，诱导神经母细胞瘤细胞分化。
T1920	Capivasertib AZD5363	Akt; PKA; mTOR; Autophagy	Autophagy; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
	Capivasertib (AZD5363) 是一种广谱的 AKT 抑制剂，对 Akt1、Akt2 和 Akt3 均有抑制活性 (IC50=3/7/7 nM)，具有口服活性。Capivasertib 具有抗肿瘤活性，可以用于治疗乳腺癌。
T14034	3CAI	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	3CAI 是特异性的AKT1和AKT2抑制剂。
T1911	Afuresertib GSK2110183C,GSK2110183	ROCK; Akt; PKC	Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Stem Cells
	Afuresertib (GSK2110183) 是一个选择性，ATP 竞争性，口服有效的泛 Akt 抑制剂，作用于 Akt1、Akt2和 Akt3，Ki 值分别为 0.08、2、2.6 nM。
T6252	Ipatasertib GDC-0068,RG7440,帕他色替	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Ipatasertib (GDC-0068) 是选择性的，ATP 竞争性的pan-Akt 抑制剂，能够抑制Akt1 (IC50:5 nM)，Akt2 (IC50:18 nM)，Akt3 (IC50:8 nM)。
T3346	AKT inhibitor VIII AKTi-1/2	Apoptosis; Akt	Apoptosis; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	AKT inhibitor VIII (AKTi-1/2) 是一种细胞渗透的喹喔啉化合物，可逆的选择性抑制Akt1、Akt2和Akt3的活性，IC50值分别为 58 nM、210 nM 和 2119 nM。
T16836	SAFit2	FKBP	Apoptosis; Autophagy; Immunology/Inflammation
	SAFit2是一种高效、具有选择性的fk506结合蛋白51(FKBP51)抑制剂（Ki：6 nM）。SAFit2能增强AKT2-AS160的结合，参与体内糖皮质激素释放的下游反应，是治疗肥胖、慢性疼痛、抑郁和焦虑的候选化合物。
T6304	AT7867	Akt; PKA; S6 Kinase	Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
	AT7867 是 ATP 竞争性的Akt1/Akt2/Akt3和p70S6K/PKA 抑制剂，IC50分别为 32、17、47 和 85、20 nM。
T6849	Uprosertib GSK2141795,GSK795,优普色替	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Uprosertib (GSK2141795) 是一种有效的，选择性的 Akt 广谱抑制剂，对 Akt1/Akt2/Akt3 的 IC50值分别为 180/328/38 nM。
T2482	AT13148	ROCK; SGK; Akt; PKA; S6 Kinase	Cell Cycle/Checkpoint; Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors
	AT13148 是一种 ATP 竞争性 AGC 激酶口服抑制剂，能够抑制 Akt1/Akt2/Akt3、p70S6K、PKA 和 ROCKI/ROCKII 的活性，IC50值分别为 38/402/50、8、3 和 6 nM/4 nM。
T6285	GSK-690693 GSK690693	Serine Protease; Akt; PKC; AMPK; Autophagy	Autophagy; Chromatin/Epigenetic; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Proteases/Proteasome
	GSK-690693 是一种泛 Akt 抑制剂，对 Akt1、Akt2和 Akt3的 IC50分别为 2 nM、13 nM 和9 nM。它也是一种 AMPK 的抑制剂，影响 ULK1 的活性，并能显著抑制 STING 依赖的 IRF3 的激活。
T6303	CCT128930	Akt; PKA; S6 Kinase; Autophagy	Autophagy; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
	CCT128930 是一种 ATP 竞争性，选择性 AKT 抑制剂。它通过靶向 AKT 的 Met282 (PKA-AKT 嵌合体的 Met173)，对 PKA 激酶具有 28 倍的选择性，对 p70S6K 具有 20 倍的选择性，具有抗肿瘤活性。
T11664	INY-03-041	Others	Others
	INY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide.
T15428	Uprosertib hydrochloride GSK2141795 (hydrochloride)	Others	Others
	Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively).
T61680	AKT-IN-5
	AKT-IN-5 (Example 8) is a chemical compound known as an Akt inhibitor, specifically targeting Akt1 and Akt2. Its potency is reflected in IC50 values of 450 nM and 400 nM for Akt1 and Akt2, respectively [1].
T10275	AKT-IN-3	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	AKT-IN-3 is a potent, orally active low hERG blocking Akt inhibitor (IC50: 1.4 nM, 1.2 nM, and 1.7 nM for Akt1, Akt2, and Akt3). AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1
T39930	MS98
	MS98 is a highly effective and specific PROTAC AKT degrader compound that effectively targets and depletes total AKT (T-AKT) within cells, exhibiting a DC 50 value of 78 nM. This compound readily binds to AKT1, AKT2, and AKT3 with respective dissociation constants (Kd s) of 4 nM, 140 nM, and 8.1 nM.
T25791	Merck-22-6 Merck 22 6,Merck226
	Merck-22-6 is an allosteric dual inhibitor of Akt1, Akt2.
T74983	MS15
	MS15 是一种有效且选择性的AKTPROTAC 降解剂。 MS15 可抑制 AKT1、-2 和 -3 活性，IC50值分别为 798 nM、90 nM 和 544 nM。
T62842	AKT-IN-8
	AKT-IN-8 是一种 AKT 的有效抑制剂，能够作用于 AKT1 (IC50: 4.46 nM)、AKT2 (IC50: 2.44 nM) 和 AKT3 (IC50: 9.47 nM)。
T39899	Hu7691	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	Hu7691 是一种具有口服活性、选择性和高效性的 Akt 抑制剂，抑制 Akt1、Akt2 和 Akt3，抑制神经母细胞瘤细胞增殖，诱导神经母细胞瘤细胞的分化。
T63039	AKT-IN-13
	AKT-IN-13 (compound 4b) 是一种 Akt 的有效抑制剂，能够作用于 Akt1 (IC50: 1.6 nM)、Akt2 (IC50: 2.4 nM) 和 Akt3 (IC50: 0.3 nM) 。AKT-IN-13 能够用于研究抗癌。
T39928	MS170
	MS170 is a highly effective and specific PROTAC AKT degrader compound that exhibits potent activity. It efficiently reduces the levels of total AKT (T-AKT) within cells, with a DC 50 value of 32 nM. Furthermore, MS170 demonstrates strong binding affinity towards AKT isoforms, specifically AKT1, AKT2, and AKT3, with respective dissociation constants (Kd) of 1.3 nM, 77 nM, and 6.5 nM.
T74001	INY-03-041 trihydrochloride
	INY-03-041 trihydrochloride 是一种有效的、高选择性的、基于PROTAC 的泛-AKT 降解剂，由ATP 竞争性AKT 抑制剂Ipatasertib 结合Lenalidomide 组成。INY-03-041 trihydrochloride 可抑制AKT1，AKT2和AKT3，IC50分别为 2.0 nM，6.8 nM 和 3.5 nM。
T21624	AT7867 dihydrochloride
	AT7867 dihydrochloride 是一种有效的ATP 竞争性的Akt1/Akt2/Akt3和p70S6K/PKA 抑制剂，IC50值分别为 32 nM/17 nM/47 nM 和 85 nM/20 nM，具有癌症治疗的潜力。
T38847	Vevorisertib Vevorisertib,ARQ 751
	Vevorisertib (ARQ 751) is a highly effective oral compound that selectively inhibits pan-AKT serine/threonine kinases such as AKT1 (with an IC50 value of 0.55 nM), AKT2 (with an IC50 value of 0.81 nM), and AKT3 (with an IC50 value of 1.31 nM). This compound, either as a standalone treatment option or in combination with other anti-cancer agents, is ideally suited for conducting research on solid tumors characterized by PIK3CA/AKT/PTEN mutations[4].
T63200	NTQ1062
	NTQ1062 (compound 22b) 是口服具有活力的、有效的Akt 抑制剂，能够作用于 Akt1 (IC50: 0.4 nM)、Akt2 (IC50: 6.3 nM) 和 Akt3 (IC50: 0.1 nM)。NTQ1062 对多种癌细胞表现出抗增殖作用，能够将细胞周期阻滞在 G0/G1 期，诱导细胞凋亡 (apoptosis)。NTQ1062 在 LNCap 异种移植瘤小鼠模型中显示出显著的的抗肿瘤效果。
T77968	MS15 TFA	PROTACs	PROTAC
	MS15 TFA，作为一种有效且选择性的AKTPROTAC降解剂，能够针对AKT-1、-2 及 -3活性进行抑制，其IC50值分别为798 nM、90 nM和544 nM。
T81784	MK-2206 free base	Akt	Cytoskeletal Signaling; PI3K/Akt/mTOR signaling
	MK-2206 free base是一种口服活性、高选择性的变构Akt抑制剂，IC50分别针对Akt1、Akt2、Akt3为8、12和65 nM 。多种乳腺癌细胞系、PIK3CA突变以及PTEN缺失细胞系对此化合物敏感，显示出抗癌活性。
T62609	MK-2206
	MK-2206 是一种具有口服具有活力的、高效选择性的变构 Akt 抑制剂，能够作用于 Akt1 (IC50: 8 nM)、Akt2 (IC50: 12 nM) 和 Akt3 (IC50: 65 nM)。许多乳腺癌细胞系、PIK3CA 突变体和 PTEN 丢失细胞系对 MK-2206 敏感。MK-2206 具有抗癌作用。
T62149	ALM301
	ALM301 是一种高度特异性的、口服具有活力的 AKT 抑制剂，能够作用于 AKT1 (IC50: 0.13 μM)、AKT2 (IC50: 0.09 μM) 和 AKT3 (IC50: 2.75 μM)。ALM301 在体外能够抑制 AKT 磷酸化，并对下游信号具有调节作用。ALM301 对癌细胞增殖和肿瘤生长表现出抑制作用。
T62907	TAS-117 hydrochloride
	TAS-117 hydrochloride 是一种选择性的、有效的、口服具有活力的别构 Akt 抑制剂，作用于 Akt1 (IC50: 4.8 nM) 、Akt2 (IC50: 1.6 nM) 和 Akt3 (IC50: 44 nM)。TAS-117 hydrochloride 能够激发抗骨髓瘤活性，增强蛋白酶体抑制诱导的致命内质网应激，可以诱导细胞凋亡和自噬。
T6303L	CCT128930 hydrochloride CCT128930 hydrochloride(885499-61-6 Free base)	Apoptosis; Akt; PKA; mTOR; Autophagy	Apoptosis; Autophagy; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors
	CCT128930 hydrochloride (CCT128930 hydrochloride) 是一种选择性 AKT 抑制剂，具有抗肿瘤活性。它通过靶向 AKT 的 Met282 (PKA-AKT 嵌合体的 Met173)，对 PKA 激酶具有 28 倍的选择性，对 p70S6K 具有 20 倍的选择性。
T17346	9-Decyn-1-ol	Others	Others
	9-Decyn-1-ol is an alkyl/ether-based PROTAC linker suitable for synthesizing PROTACs. It serves as a conjugation agent to combine GDC-0068 and Lenalidomide, resulting in the formation of INY-03-041. INY-03-041 is a potent and highly selective pan-Akt degrader that operates through the PROTAC mechanism. It effectively inhibits Akt1, Akt2, and Akt3 with IC50 values of 2.0 nM, 6.8 nM, and 3.5 nM, respectively[1].
T22247	Miransertib (ARQ 092) HCl
	Miransertib hydrochloride (ARQ-092 hydrochloride) is a powerful, orally bioavailable, selective, and allosteric inhibitor of Akt. It exhibits an inhibitory concentration (IC50) of 2.7 nM, 14 nM, and 8.1 nM against Akt1, Akt2, and Akt3, respectively. In addition to its Akt inhibitory activity, Miransertib hydrochloride also demonstrates significant potency as an inhibitor of the AKT1-E17K mutant protein. This compound shows promise in research related to PI3K/AKT-driven tumors and Proteus syndrom...
T18065	Lenalidomide-C9-aldehyde	Others	Others
	Lenalidomide-C9-aldehyde is a synthesized E3 ligase ligand-linker conjugate that incorporates the Lenalidomide based cereblon ligand and a linker. Lenalidomide-C9-aldehyde can be used in the synthesis of a series of PROTACs, such as INY-03-041. INY-03-041
T13134	(+)-Tetrabenazine (+)-TBZ,(3R,11bR)-Tetrabenazine,(3R,11bR)-TBZ	Monoamine Transporter	Membrane transporter/Ion channel
	(+)-Tetrabenazine ((3R,11bR)-Tetrabenazine) 是一种可逆的囊泡单胺转运蛋白2 (VMAT-2)抑制剂，对 VMAT2转运的抑制作用是VMAT1的10倍。
T28923	TAS-117 TAS117,TAS 117
	TAS-117, a PKB/Akt inhibitor, is used potentially for the treatment of solid tumors.
T39519	GSK269962A hydrochloride GSK 269962 hydrochloride
	GSK269962A hydrochloride (GSK 269962 hydrochloride) is a highly potent inhibitor of ROCK1 and ROCK2, with IC50 values of 1.6 nM and 4 nM, respectively, for recombinant human isoforms. This compound exhibits both anti-inflammatory and vasodilatory properties.

化合物

Akt1 and Akt2-IN-1

Cat.No: T14152

Target: Akt

Cat.No: T3467

Synonym: ARQ-092,AKT inhibitor 2

Target: Akt, Parasite

Ipatasertib dihydrochloride

Cat.No: T15374

Synonym: GDC-0068 dihydrochloride,RG-7440 dihydrochloride

Target: Akt, PKA

Afuresertib hydrochloride

Cat.No: T7885

Target: ROCK, Akt, PKC

Cat.No: T23695

Target: Akt

Cat.No: T7315

Target: Akt

MK-2206 dihydrochloride

Cat.No: T1952

Synonym: MK-2206 2HCl

Target: Apoptosis, Akt, Autophagy

Vevorisertib trihydrochloride

Cat.No: T38846

Synonym: ARQ 751 trihydrochloride

Target: Akt

Cat.No: T14072

Target: ERK, VEGFR, GSK-3, FLT, Casein Kinase, MAPK, Akt, PKA, Chk, CDK, Src, PKC, S6 Kinase

Hu7691 free base

Cat.No: T39733

Target: Akt

Cat.No: T1920

Synonym: AZD5363

Target: Akt, PKA, mTOR, Autophagy

Cat.No: T14034

Target: Akt

Cat.No: T1911

Synonym: GSK2110183C,GSK2110183

Target: ROCK, Akt, PKC

Cat.No: T6252

Synonym: GDC-0068,RG7440,帕他色替

Target: Akt

AKT inhibitor VIII

Cat.No: T3346

Synonym: AKTi-1/2

Target: Apoptosis, Akt

Cat.No: T16836

Target: FKBP

Cat.No: T6304

Target: Akt, PKA, S6 Kinase

Cat.No: T6849

Synonym: GSK2141795,GSK795,优普色替

Target: Akt

Cat.No: T2482

Target: ROCK, SGK, Akt, PKA, S6 Kinase

Cat.No: T6285

Synonym: GSK690693

Target: Serine Protease, Akt, PKC, AMPK, Autophagy

Cat.No: T6303

Target: Akt, PKA, S6 Kinase, Autophagy

Cat.No: T11664

Target: Others

Uprosertib hydrochloride

Cat.No: T15428

Synonym: GSK2141795 (hydrochloride)

Target: Others

Cat.No: T61680

Cat.No: T10275

Target: Akt

Cat.No: T39930

Cat.No: T25791

Synonym: Merck 22 6,Merck226

Cat.No: T74983

Cat.No: T62842

Cat.No: T39899

Target: Akt

Cat.No: T63039

Cat.No: T39928

INY-03-041 trihydrochloride

Cat.No: T74001

AT7867 dihydrochloride

Cat.No: T21624

Cat.No: T38847

Synonym: Vevorisertib,ARQ 751

Cat.No: T63200

Cat.No: T77968

Target: PROTACs

MK-2206 free base

Cat.No: T81784

Target: Akt

Cat.No: T62609

Cat.No: T62149

TAS-117 hydrochloride

Cat.No: T62907

CCT128930 hydrochloride

Cat.No: T6303L

Synonym: CCT128930 hydrochloride(885499-61-6 Free base)

Target: Apoptosis, Akt, PKA, mTOR, Autophagy

Cat.No: T17346

Target: Others

Miransertib (ARQ 092) HCl

Cat.No: T22247

Lenalidomide-C9-aldehyde

Cat.No: T18065

Target: Others

(+)-Tetrabenazine

Cat.No: T13134

Synonym: (+)-TBZ,(3R,11bR)-Tetrabenazine,(3R,11bR)-TBZ

Target: Monoamine Transporter

Cat.No: T28923

Synonym: TAS117,TAS 117

GSK269962A hydrochloride

Cat.No: T39519

Synonym: GSK 269962 hydrochloride

Cat. No.	Product Name	Target	Signaling Pathways
T2790	Oridonin NSC-250682,Rubescenin,冬凌草甲素,Isodonol,Rubescensin A	Akt; Antibacterial	Cytoskeletal Signaling; Microbiology/Virology; PI3K/Akt/mTOR signaling
	Oridonin (NSC-250682) 是从Rabdosia rubescens 中得到的二萜，是一种AKT 抑制剂，对 AKT1 和 AKT2 的IC50值分别为 8.4 和 8.9 μM，具有抗菌、抗炎、抗肿瘤等功效。

天然产物

Cat.No: T2790

Synonym: NSC-250682,Rubescenin,冬凌草甲素,Isodonol,Rubescensin A

Target: Akt, Antibacterial

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼